X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (195) 195
Newspaper Article (79) 79
Publication (31) 31
Dissertation (17) 17
Book / eBook (7) 7
Book Review (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (71) 71
oncology (69) 69
female (47) 47
male (42) 42
middle aged (32) 32
aged (30) 30
cancer (26) 26
adult (25) 25
article (24) 24
united states (24) 24
aged, 80 and over (18) 18
colorectal cancer (18) 18
african americans (16) 16
research (16) 16
survival (16) 16
chemotherapy (15) 15
abridged index medicus (14) 14
mortality (13) 13
risk factors (12) 12
treatment outcome (12) 12
breast-cancer (11) 11
risk (11) 11
education (10) 10
african-americans (9) 9
fluorouracil (9) 9
hematology, oncology and palliative medicine (9) 9
prognosis (9) 9
race (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
bevacizumab (8) 8
care and treatment (8) 8
clinical trials (8) 8
colon-cancer (8) 8
colorectal neoplasms - mortality (8) 8
colorectal-cancer (8) 8
disease-free survival (8) 8
neoplasms - therapy (8) 8
surgery (8) 8
disparities (7) 7
health aspects (7) 7
medical research (7) 7
medicine (7) 7
medicine, general & internal (7) 7
metastasis (7) 7
neoplasm staging (7) 7
neoplasms - economics (7) 7
patients (7) 7
sociology (7) 7
adjuvant chemotherapy (6) 6
african americans - statistics & numerical data (6) 6
colon cancer (6) 6
colorectal neoplasms - drug therapy (6) 6
colorectal neoplasms - pathology (6) 6
diagnosis (6) 6
drugs (6) 6
leucovorin (6) 6
neoplasms - drug therapy (6) 6
oxaliplatin (6) 6
pharmacology & pharmacy (6) 6
retrospective studies (6) 6
studies (6) 6
tumors (6) 6
united-states (6) 6
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
breast cancer (5) 5
care (5) 5
case-control studies (5) 5
children (5) 5
cohort studies (5) 5
colonic neoplasms - drug therapy (5) 5
colorectal neoplasms - ethnology (5) 5
education & educational research (5) 5
european continental ancestry group (5) 5
fluorouracil - administration & dosage (5) 5
health (5) 5
health care disparities (5) 5
health care sciences & services (5) 5
irinotecan (5) 5
linguistics (5) 5
males (5) 5
precision medicine (5) 5
public, environmental & occupational health (5) 5
racial disparities (5) 5
racial-differences (5) 5
socioeconomic factors (5) 5
specific language impairment (5) 5
survival rate (5) 5
united states - epidemiology (5) 5
urban schools (5) 5
young adult (5) 5
academic achievement (4) 4
adolescent (4) 4
african american studies (4) 4
age (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
association (4) 4
camptothecin - administration & dosage (4) 4
camptothecin - analogs & derivatives (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2019, Volume 37, Issue 29, pp. 2620 - 2620
PURPOSERegular physical activity is associated with reduced risk of recurrence and mortality in patients with nonmetastatic colorectal cancer. Its influence on... 
BREAST-CANCER | ADJUVANT CHEMOTHERAPY | MORTALITY | III COLON-CANCER | OBESITY | ONCOLOGY | INSULIN-RESISTANCE | BODY-MASS INDEX | RISK | EXERCISE | INFLAMMATORY MARKERS | ORIGINAL REPORTS
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | FIRE-3 | THERAPY | FOLFIRI PLUS CETUXIMAB | PHASE-II | IRINOTECAN | OXALIPLATIN | FLUOROURACIL | TUMORS | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Randomization | Oxaliplatin | Monoclonal antibodies | Tumors
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 05/2013, Volume 35, Issue 3, pp. 167 - 170
To describe general data on nucleic acid/serology testing and report the first hepatitis B-nucleic acid testing yield case of an immunized donor in Brazil. A... 
Hepatitis B/diagnosis | HIV | Reverse transcriptase polymerase chain reaction | Hepatitis C/ diagnosis | Hepatitis B virus | Hepatitis C virus | Blood donors | diagnosis | Hepatitis C | Original | Hepatitis B | Hepatitis C/diagnosis
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1806-0870, 06/2013, Volume 35, Issue 3, pp. 167 - 170
Objective: To describe general data on nucleic acid/serology testing and report the first hepatitis B-nucleic acid testing yield case of an immunized donor in... 
MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2005, Volume 23, Issue 16_suppl, pp. 3533 - 3533
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2011, Volume 29, Issue 28, pp. 3816 - 3824
Patients in specific vulnerable population groups suffer disproportionately from cancer. The elimination of cancer disparities is critically important for... 
ONCOLOGY | HEALTH-INSURANCE | RACE | Health Care Reform | Neoplasms - therapy | Neoplasms - economics | Delivery of Health Care | Health Services Accessibility | United States | Humans | Healthcare Disparities | Female | Male | Health Care Surveys
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 1, pp. 15 - 20
Purpose Death from noncancer causes (competing mortality) is an important event in head and neck cancer, but studies identifying predictors of this event are... 
SURVIVAL | IRRADIATION | THERAPY | ONCOLOGY | CONCURRENT CHEMOTHERAPY | SQUAMOUS-CELL CARCINOMA | CHEMORADIOTHERAPY | LOCOREGIONALLY ADVANCED HEAD | LOCALLY ADVANCED HEAD | RADIOTHERAPY | FLUOROURACIL | Body Mass Index | Disease-Free Survival | Humans | Middle Aged | Adolescent | Aged, 80 and over | Adult | Female | Male | Aged | Head and Neck Neoplasms - mortality | Cohort Studies
Journal Article
BRITISH JOURNAL OF AESTHETICS, ISSN 0007-0904, 10/2019, Volume 59, Issue 4, pp. 429 - 447
In 'Listening to Music Together', Nick Zangwill offers three arguments which aim to establish that listening to music can never be a joint activity. If any of... 
PERCEPTION | PHILOSOPHY | ART
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2018, Volume 82, Issue 2, pp. 309 - 317
Sirolimus is a mammalian target of rapamycin (mTOR) inhibitor. Metformin may potentiate mTOR inhibition by sirolimus while mitigating its adverse effects. We... 
Pharmacodynamics | Medicine & Public Health | Sirolimus | Oncology | Cancer Research | Metformin | Solid tumors | Pharmacology/Toxicology | P70S6K and mTOR | TARGET | RISK | MTOR | ONCOLOGY | PATHWAY | PHARMACOLOGY & PHARMACY | GENERATION | COHORT | CANCER PREVENTION | PHASE-I | Leukocytes, Mononuclear - metabolism | Phosphorylation | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Antineoplastic Combined Chemotherapy Protocols - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | Neoplasms - blood | Aged, 80 and over | Adult | Female | Metformin - administration & dosage | Ribosomal Protein S6 Kinases, 70-kDa - blood | Leukocytes, Mononuclear - drug effects | TOR Serine-Threonine Kinases - blood | Metformin - pharmacology | Sirolimus - pharmacology | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Drug Synergism | Sirolimus - administration & dosage | Pilot Projects | Adolescent | Aged | Medicine, Experimental | Medical research | Care and treatment | Hypoglycemic agents | Leptin | Tumors | TOR protein | Toxicity | Insulin-like growth factor I | Test procedures | Leukocytes (mononuclear) | Triglycerides | Pharmacology | Rapamycin | Insulin-like growth factors | Insulin | Patients | Peripheral blood mononuclear cells | Biomarkers | Inhibition | mTOR | p70S6K | pharmacodynamics | solid tumors | sirolimus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 446 - 453
Journal Article
Cancer discovery, ISSN 2159-8274, 2018, Volume 8, Issue 1, pp. 37 - 48
Journal Article